Besides, we used methyltransferase inhibitors to treat GC cells (AGS, MGC803 and SNU719) and found that the m6A levels were reduced (Figure 7D), indicating that METTL16  functions as a RNA methyltransferase to regulate the cyclin D1 expression in GC cells. Here, METTL16 is linked to gastric cancer.